newsfilter
← Latest News
Business Wire·

Imago BioSciences, Inc. Announces Closing of $134.4 Million Initial Public Offering

Imago BioSciences, Inc. ("Imago") (NASDAQ:IMGO), a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs), today announced the closing of $134.4 million in gross proceeds from its prev